These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12082362)

  • 61. Dietary boron and hormone replacement therapy as risk factors for lung cancer in women.
    Mahabir S; Spitz MR; Barrera SL; Dong YQ; Eastham C; Forman MR
    Am J Epidemiol; 2008 May; 167(9):1070-80. PubMed ID: 18343880
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cessation of hormone replacement therapy after reports of adverse findings from randomized controlled trials: evidence from a British Birth Cohort.
    Mishra G; Kok H; Ecob R; Cooper R; Hardy R; Kuh D
    Am J Public Health; 2006 Jul; 96(7):1219-25. PubMed ID: 16735620
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Social factors and periodontitis in an older population.
    Borrell LN; Burt BA; Neighbors HW; Taylor GW
    Am J Public Health; 2008 Sep; 98(9 Suppl):S95-101. PubMed ID: 18687632
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hormone replacement therapy (HRT).
    Quilliam S
    J Fam Plann Reprod Health Care; 2004 Jan; 30(1):59-61. PubMed ID: 15006319
    [No Abstract]   [Full Text] [Related]  

  • 65. Does hormone replacement therapy affect the use of prescription medicines in postmenopausal women: experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757].
    Veerus P; Fischer K; Hovi SL; Karro H; Hemminki E
    BJOG; 2007 May; 114(5):548-54. PubMed ID: 17355268
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Menopausal characteristics and physical functioning in older adulthood in the National Health and Nutrition Examination Survey III.
    Tom SE; Cooper R; Patel KV; Guralnik JM
    Menopause; 2012 Mar; 19(3):283-9. PubMed ID: 21993081
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Relationship between hormone replacement therapy and spinal osteoarthritis: a nationwide health survey analysis of the elderly Korean population.
    Park JH; Hong JY; Han K; Han SW; Chun EM
    BMJ Open; 2017 Nov; 7(11):e018063. PubMed ID: 29127229
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hormone therapy and the decreased risk of dementia in women with depression: a population-based cohort study.
    Kim H; Yoo J; Han K; Lee DY; Fava M; Mischoulon D; Jeon HJ
    Alzheimers Res Ther; 2022 Jun; 14(1):83. PubMed ID: 35710453
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Patient attitudes to commonly promoted medical interventions.
    Fitzgerald SP; Phillipov G
    Med J Aust; 2000 Jan; 172(1):9-12. PubMed ID: 10682008
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Availability of hormone replacement therapy products in Canada.
    Brown TE; Lalonde AB; Fortin C; Lea R; Azzarello D
    J Obstet Gynaecol Can; 2004 Jun; 26(6):560-3. PubMed ID: 15193200
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of Hormone Replacement Therapy on Bone Mineral Density in Korean Adults With Turner Syndrome.
    Kim S; Kim H; Lee I; Choi E; Baek J; Lee J; Kim HR; Yun BH; Choi YS; Seo SK
    J Korean Med Sci; 2024 Jan; 39(1):e9. PubMed ID: 38193328
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Attitudes toward Technology-Based Cancer Support Programs Among Korean American Breast Cancer Survivors.
    Im EO; Kim S; Jang M; Chee W
    West J Nurs Res; 2021 Aug; 43(8):732-741. PubMed ID: 33191877
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Premenopausal Hysterectomy and Risk of Ovarian Cancer in African-American Women.
    Peres LC; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy M; Cote ML; Funkhouser E; Moorman PG; Peters ES; Schwartz AG; Terry PD; Abbott SE; Camacho F; Wang F; Schildkraut JM
    Am J Epidemiol; 2017 Jul; 186(1):46-53. PubMed ID: 28444120
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer's disease.
    O'Brien J; Jackson JW; Grodstein F; Blacker D; Weuve J
    Epidemiol Rev; 2014; 36(1):83-103. PubMed ID: 24042430
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Who and what is a "population"? Historical debates, current controversies, and implications for understanding "population health" and rectifying health inequities.
    Krieger N
    Milbank Q; 2012 Dec; 90(4):634-81. PubMed ID: 23216426
    [TBL] [Abstract][Full Text] [Related]  

  • 76. History, biology, and health inequities: emergent embodied phenotypes and the illustrative case of the breast cancer estrogen receptor.
    Krieger N
    Am J Public Health; 2013 Jan; 103(1):22-7. PubMed ID: 23153126
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010.
    Sprague BL; Trentham-Dietz A; Cronin KA
    Obstet Gynecol; 2012 Sep; 120(3):595-603. PubMed ID: 22914469
    [TBL] [Abstract][Full Text] [Related]  

  • 78. "Symptom-specific or holistic": menopausal symptom management.
    Im EO; Ko Y; Hwang H; Chee W
    Health Care Women Int; 2012; 33(6):575-92. PubMed ID: 22577743
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Temporal trends in the black/white breast cancer case ratio for estrogen receptor status: disparities are historically contingent, not innate.
    Krieger N; Chen JT; Waterman PD
    Cancer Causes Control; 2011 Mar; 22(3):511-4. PubMed ID: 21188492
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Breast Cancer and Socioeconomic Status in Austria.
    Kunze U; Böhm G
    Breast Care (Basel); 2009; 4(4):263-267. PubMed ID: 21049072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.